Novisc Pharma sp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-12-13
Share capital
40,000.00 PLN
Activity description

Novisc Pharma is a medical devices company offering hyaluronic acid products for orthopedic use, including Hya-Joint 1% and Hya-Joint Plus 2%, as well as Chondrum+ and nitrile gloves. Hya-Joint Plus is a concentrated 2% hyaluronic acid gel developed for single-injection treatment, while Hya-Joint is a 1% formulation. The products are presented as supporting joint lubrication, flexibility and mobility.

Registered address
Domaniewska 47/10, 02-672 Warszawa, Poland
Website
Email

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$2,020

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 383 days for 2022).

  • 202529/07/2026
  • 202415/07/2025
  • 202329/11/2024
  • 202201/08/2024
  • 202113/10/2022
  • 202030/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods704 / 1,138
Top 62%
Division · Wholesale trade10,512 / 20,082
Top 52%
City · Warszawa18,130 / 56,857
Top 32%
Voivodeship · Mazowieckie25,377 / 77,058
Top 33%
Country · Poland100,594 / 297,566
Top 34%

Results vs industry

Revenue
This companyUSD 806.02kMedianUSD 1.08mAverageUSD 22.29m
Net profit
This companyUSD 22.65kMedianUSD 38.88kAverageUSD 876.69k
Operating costs
This companyUSD 775.64kMedianUSD 962.19kAverageUSD 20.97m
Assets
This companyUSD 475.47kMedianUSD 609.97kAverageUSD 11.79m

Offer

Websites

Authorized Representatives

Konrad Antoni Szostek age 39 – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
380$10,264.7295%
Others
20$540.255%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2013-02-06.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $68,083.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,989
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$193

Competitors

Name
Aqvitox Polska sp. z o.o.
Fidia Pharma Polska sp. z o.o.
NEWU sp. z o.o.
Atradis Polska sp. z o.o.
Aptissen Polska sp. z o.o.
Komak-Med sp. z o.o. + limited partnership
Medical Expert Poland sp. z o.o.
JJH Medical Bartosz Hiczkiewicz sp. k.
Capeypharma sp. z o.o.
TNS Silesia sp. z o.o.

Change history

DateEvent
2015-07-20PKD change
2012-12-13Entered in the register

FAQ

Last updated: 2026-09-19